FIELD: medicine, pharmaceutics.
SUBSTANCE: there is offered an agent for prevention and treatment of alcoholism and opiomania containing mixed Nalmefene and polylactide-co-glycolide in the mass ratio of Nalmefene to polylactide-co-glycolide 1:0.5 to 1:1.5, in the form of microspheres. There is disclosed considerable effect of delayed and slow release of an introduced active principle.
EFFECT: ensured metered therapeutic concentration in biological fluids of the patient at the required level throughout the whole period of treatment.
2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR PREVENTION AND TREATMENT OF ALCOHOLIC DEPENDENCE | 2009 |
|
RU2421228C1 |
| AGENT FOR PREVENTION AND TREATMENT OF ALCOHOLISM AND METHOD OF ITS APPLICATION | 2007 |
|
RU2343908C1 |
| COMPOSITIONS AND METHODS OF PREVENTING AND TREATING ADDICTIONS | 2008 |
|
RU2492858C2 |
| METHOD OF ALCOHOLISM TREATMENT | 1991 |
|
RU2090190C1 |
| METHOD AND DOSING SYSTEM FOR TREATING DRUG AND/OR ALCOHOLIC ADDICTION | 2005 |
|
RU2314794C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOLISM, DRUG ADDICTION AND CHEMICAL ABUSE WITH IMPROVED NALTREXONE RELEASE PROFILE | 2011 |
|
RU2471478C1 |
| USE OF MAVOGLURANT TO REDUCE ALCOHOL USE OR TO PREVENT RECURRENT ALCOHOL USE | 2018 |
|
RU2806869C2 |
| IMPLANTABLE MEDICATION DISULFIRAM-BASED FOR TREATMENT OF ALCOHOL OR OPIATE-DEPENDENT PATIENT | 2012 |
|
RU2475272C1 |
| METHOD FOR ASSESSING ALCOHOLIC ANOSOGNOSIA AND DIFFERENTIATED APPROACHES TO PSYCHOTHERAPEUTIC AND MEDIATED PSYCHOPHARMACOLOGICAL CORRECTION OF ALCOHOLIC ANOSOGNOSIA IN ALCOHOL ADDICTED PATIENTS | 2011 |
|
RU2509526C2 |
| METHOD FOR ESTIMATING INDICATIONS FOR PRESCRIBING DRUG PREPARATIONS INCOMPATIBLE WITH ALCOHOL INGESTION | 2012 |
|
RU2512764C2 |
